戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  the majority of normal tissue obtained from reduction mammoplasty.
2 l human breast epithelial cells (HBECs) from reduction mammoplasty.
3 X-2 expression in a series of specimens from reduction mammoplasty, adenosis, ductal carcinoma in sit
4 stry in 17 normal breast tissue samples from reduction mammoplasties and in two independent tissue mi
5                 Human skin was obtained from reduction mammoplasties and prepared for culture.
6 s, including breast fibroblasts derived from reduction mammoplasty and tumor tissues, and human umbil
7 elial ducts within tumors and in tissue from reduction mammoplasties, and by epithelial-derived tumor
8 t cells separately purified from a set of 10 reduction mammoplasties by using a double antibody magne
9 n approach combining partial mastectomy with reduction mammoplasty could provide a safe oncologic pro
10                  Whereas inclusion of normal reduction mammoplasty fibroblasts inhibit or retard morp
11                       Samples from bilateral reduction mammoplasty from 10 women without any clinical
12 6, and 40), established from tissue taken at reduction mammoplasty from three individuals.
13 normalities were also selected as a control (reduction mammoplasty group).
14                      She underwent bilateral reduction mammoplasty in June 1995 to treat progressive
15 ormal mammary epithelial cells enriched from reduction mammoplasties (n = 9).
16 ved from a diseased tissue (e.g. MCF10A) and reduction mammoplasty of normal breast tissue (e.g. 184A
17 d either from breast cancer patients or from reduction mammoplasty operations expressed comparable es
18  assembled from 55 donors that had undergone reduction mammoplasties or risk reduction mastectomies.
19 issue was collected from women who underwent reduction mammoplasty or breast cancer surgery.
20 ng human breast epithelial cells from either reduction mammoplasty or nonmalignant breast cell lines,
21 undergoing partial mastectomy and concurrent reduction mammoplasty performed at our institution from
22  consecutive simultaneous partial mastectomy/reduction mammoplasty procedures were performed in 79 pa
23 amples from 29 noncancer patients undergoing reduction mammoplasty served as controls.
24 aneous fat and evaluation of the skin during reduction mammoplasty surgery in two patients.
25         A partial mastectomy with concurrent reduction mammoplasty technique is a viable option for b
26 at varying degrees of risk (those undergoing reduction mammoplasties, those with atypical hyperplasti
27 ammary epithelial cells (HMEC) isolated from reduction mammoplasty tissue are proliferative for sever
28 mmary epithelial cells (HMECs) isolated from reduction mammoplasty tissue of seven individual donors.
29 lial cell (HMEC) culture model, derived from reduction mammoplasty tissue, and found that ectopic exp
30 ting functionally normal breast tissues from reduction mammoplasty tissues, in what we term the human
31                        Adult human skin from reduction mammoplasties was prepared for culture on NetW
32 east tissue from healthy patients undergoing reduction mammoplasty was also studied.
33 ly removed from 40 women undergoing elective reduction mammoplasty were extracted by a solid-phase pr